These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
297 related articles for article (PubMed ID: 21812966)
1. Targeting surface nucleolin with multivalent HB-19 and related Nucant pseudopeptides results in distinct inhibitory mechanisms depending on the malignant tumor cell type. Krust B; El Khoury D; Nondier I; Soundaramourty C; Hovanessian AG BMC Cancer; 2011 Aug; 11():333. PubMed ID: 21812966 [TBL] [Abstract][Full Text] [Related]
2. Targeting surface nucleolin with a multivalent pseudopeptide delays development of spontaneous melanoma in RET transgenic mice. El Khoury D; Destouches D; Lengagne R; Krust B; Hamma-Kourbali Y; Garcette M; Niro S; Kato M; Briand JP; Courty J; Hovanessian AG; Prévost-Blondel A BMC Cancer; 2010 Jun; 10():325. PubMed ID: 20573279 [TBL] [Abstract][Full Text] [Related]
3. Suppression of tumor growth and angiogenesis by a specific antagonist of the cell-surface expressed nucleolin. Destouches D; El Khoury D; Hamma-Kourbali Y; Krust B; Albanese P; Katsoris P; Guichard G; Briand JP; Courty J; Hovanessian AG PLoS One; 2008 Jun; 3(6):e2518. PubMed ID: 18560571 [TBL] [Abstract][Full Text] [Related]
4. Suppression of tumorigenicity of rhabdoid tumor derived G401 cells by the multivalent HB-19 pseudopeptide that targets surface nucleolin. Krust B; El Khoury D; Soundaramourty C; Nondier I; Hovanessian AG Biochimie; 2011 Mar; 93(3):426-33. PubMed ID: 21040752 [TBL] [Abstract][Full Text] [Related]
5. Nucleolin mediates the antiangiogenesis effect of the pseudopeptide N6L. Birmpas C; Briand JP; Courty J; Katsoris P BMC Cell Biol; 2012 Nov; 13():32. PubMed ID: 23146273 [TBL] [Abstract][Full Text] [Related]
6. Cell-surface nucleolin acts as a central mediator for carcinogenic, anti-carcinogenic, and disease-related ligands. Fujiki H; Watanabe T; Suganuma M J Cancer Res Clin Oncol; 2014 May; 140(5):689-99. PubMed ID: 24469254 [TBL] [Abstract][Full Text] [Related]
7. The anti-HIV pentameric pseudopeptide HB-19 binds the C-terminal end of nucleolin and prevents anchorage of virus particles in the plasma membrane of target cells. Nisole S; Said EA; Mische C; Prevost MC; Krust B; Bouvet P; Bianco A; Briand JP; Hovanessian AG J Biol Chem; 2002 Jun; 277(23):20877-86. PubMed ID: 11919179 [TBL] [Abstract][Full Text] [Related]
8. Surface nucleolin participates in both the binding and endocytosis of lactoferrin in target cells. Legrand D; Vigié K; Said EA; Elass E; Masson M; Slomianny MC; Carpentier M; Briand JP; Mazurier J; Hovanessian AG Eur J Biochem; 2004 Jan; 271(2):303-17. PubMed ID: 14717698 [TBL] [Abstract][Full Text] [Related]
9. The anti-HIV pseudopeptide HB-19 forms a complex with the cell-surface-expressed nucleolin independent of heparan sulfate proteoglycans. Nisole S; Krust B; Callebaut C; Guichard G; Muller S; Briand JP; Hovanessian AG J Biol Chem; 1999 Sep; 274(39):27875-84. PubMed ID: 10488134 [TBL] [Abstract][Full Text] [Related]
10. The anti-HIV cytokine midkine binds the cell surface-expressed nucleolin as a low affinity receptor. Said EA; Krust B; Nisole S; Svab J; Briand JP; Hovanessian AG J Biol Chem; 2002 Oct; 277(40):37492-502. PubMed ID: 12147681 [TBL] [Abstract][Full Text] [Related]
11. Multivalent pseudopeptides targeting cell surface nucleoproteins inhibit cancer cell invasion through tissue inhibitor of metalloproteinases 3 (TIMP-3) release. Destouches D; Huet E; Sader M; Frechault S; Carpentier G; Ayoul F; Briand JP; Menashi S; Courty J J Biol Chem; 2012 Dec; 287(52):43685-93. PubMed ID: 23109338 [TBL] [Abstract][Full Text] [Related]
12. A novel receptor - ligand pathway for entry of Francisella tularensis in monocyte-like THP-1 cells: interaction between surface nucleolin and bacterial elongation factor Tu. Barel M; Hovanessian AG; Meibom K; Briand JP; Dupuis M; Charbit A BMC Microbiol; 2008 Sep; 8():145. PubMed ID: 18789156 [TBL] [Abstract][Full Text] [Related]
13. The cell surface expressed nucleolin is a glycoprotein that triggers calcium entry into mammalian cells. Losfeld ME; Khoury DE; Mariot P; Carpentier M; Krust B; Briand JP; Mazurier J; Hovanessian AG; Legrand D Exp Cell Res; 2009 Jan; 315(2):357-69. PubMed ID: 19026635 [TBL] [Abstract][Full Text] [Related]
14. Midkine, a cytokine that inhibits HIV infection by binding to the cell surface expressed nucleolin. Hovanessian AG Cell Res; 2006 Feb; 16(2):174-81. PubMed ID: 16474431 [TBL] [Abstract][Full Text] [Related]
15. Interfering with the interaction between ErbB1, nucleolin and Ras as a potential treatment for glioblastoma. Goldshmit Y; Trangle SS; Kloog Y; Pinkas-Kramarski R Oncotarget; 2014 Sep; 5(18):8602-13. PubMed ID: 25261371 [TBL] [Abstract][Full Text] [Related]
16. Nucleolin inhibits Fas ligand binding and suppresses Fas-mediated apoptosis in vivo via a surface nucleolin-Fas complex. Wise JF; Berkova Z; Mathur R; Zhu H; Braun FK; Tao RH; Sabichi AL; Ao X; Maeng H; Samaniego F Blood; 2013 Jun; 121(23):4729-39. PubMed ID: 23599269 [TBL] [Abstract][Full Text] [Related]
17. Nucleolin down-regulation is involved in ADP-induced cell cycle arrest in S phase and cell apoptosis in vascular endothelial cells. Wang W; Luo J; Xiang F; Liu X; Jiang M; Liao L; Hu J PLoS One; 2014; 9(10):e110101. PubMed ID: 25290311 [TBL] [Abstract][Full Text] [Related]
18. Disrupting the oncogenic synergism between nucleolin and Ras results in cell growth inhibition and cell death. Schokoroy S; Juster D; Kloog Y; Pinkas-Kramarski R PLoS One; 2013; 8(9):e75269. PubMed ID: 24086490 [TBL] [Abstract][Full Text] [Related]
19. Targeting nucleolin for better survival in diffuse large B-cell lymphoma. Jain N; Zhu H; Khashab T; Ye Q; George B; Mathur R; Singh RK; Berkova Z; Wise JF; Braun FK; Wang X; Patel K; Xu-Monette ZY; Courty J; Young KH; Sehgal L; Samaniego F Leukemia; 2018 Mar; 32(3):663-674. PubMed ID: 28690315 [TBL] [Abstract][Full Text] [Related]
20. Nucleolin overexpression in breast cancer cell sub-populations with different stem-like phenotype enables targeted intracellular delivery of synergistic drug combination. Fonseca NA; Rodrigues AS; Rodrigues-Santos P; Alves V; Gregório AC; Valério-Fernandes Â; Gomes-da-Silva LC; Rosa MS; Moura V; Ramalho-Santos J; Simões S; Moreira JN Biomaterials; 2015 Nov; 69():76-88. PubMed ID: 26283155 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]